🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Induction of #senescence: one way for #chemotherapy & #immunity to join forces against #cancer, #NKcells in the spotlight. Perspective sciencemag on #Ruscetti et al paper by Eric Vivier & @stephaniecornen Innate Pharma @univamu AP-HM - Hôpitaux Universitaires de Marseille Marseille Immunopole goo.gl/tW6jq7

A #cytostatic drug combination induces #cancer cell #senescence while also triggering #NKcell-dependent #AntitumorImmunity. #Ruscetti et al sciencemag goo.gl/BnPyg7

In an analysis of KEYNOTE-028, T-cell–inflamed gene-expression profile, PD-L1 expression, and TMB were found to predict efficacy of pembrolizumab across 20 cancer types: ascopubs.org/doi/full/10.12… #ImmunoOnc

Innate Pharma celebrates its 20th Anniversary and wishes you a happy new year 2019 ! #HappyNewYear

Come and meet us in San Francisco surrounding the JP Morgan conference J.P. Morgan #JPM19 #JPM2019

Targeting Innate Immunity in Cancer AACR 2019, Atlanta, March 31st ativsoftware.com/appinfo.php?pa… #AACR19

Ce soir Innate Pharma est fière de recevoir le prix d’honneur 2019 des #Trophées de l'#Innovation d’@univamu avec SATT Sud-Est et French Tech Aix-Marseille Région Sud

#Trophées de l'#Innovation 2019 d’@univamu avec SATT Sud-Est French Tech Aix-Marseille Région Sud, Ville de Marseille Marseille Immunopole à l’honneur : Innate Pharma reçoit le prix d’honneur tandis que @stephaniecornen remet le prix de la start-up santé à @ImcheckThx

study provides mechanistic insight on the role of KRAS in colorectal cancer resistance to immune-checkpoint inh cell.com/cancer-cell/fu… #colorectalcancer

Very proud of grad student, Dan Fu Ruan Dan Fu Ruan for stellar job in presenting effects of HLA-E expression as a major determinant of antitumor function at Keystone Symposia . Thanks very much for the opportunity to present Nicholas Huntington Eric Vivier #CarolineRobert an #LewisLanier!

Long lines of questions for the NK cell talks at Keystone Symposia Lewis Lanier, Alberto Mantovani & myself we’re inundated by Q’s on how to drug the NK cell response to cancer. Amazing time to be a cancer immunology researcher

ICYMI, @sloan_kettering scientists have identified new structures that play a critical role in one of the most protective kinds of #intercellular communication – the “lethal” interaction between a cytotoxic #Tcell and its targets: fcld.ly/qdfbmdd

Innate Pharma team this morning at AACR race against Cancer

Our friend, #AlessandroMoretta (1953–2018): cofounder of Innate Pharma, Professor at Università di Genova, major figure of #CancerImmunology, one of the founding fathers of #NKimmunotherapy with Eric Vivier See Nature Immunology goo.gl/WBw4VV Immunity goo.gl/HufV2v

The underlying biology of hyper progressive disease is unknown #AACR19

#AACR19 “#InnateImmunity & complement in #SolidTumors” Chair Eric Vivier Innate Pharma's CSO AP-HM - Hôpitaux Universitaires de Marseille @univamu Marseille Immunopole

#AACR19 Eric Vivier Innate Pharma: the #CD39-blocking antibody (IPH5201) promotes #antitumorimmunity across a wide range of tumors by preventing the production of #adenosine & promoting the accumulation of ATP in the #TumorMicroEnvironment More info goo.gl/tPymgZ

#AACR19 “#InnateImmunity & complement in #SolidTumors” Chair Eric Vivier Innate Pharma AP-HM - Hôpitaux Universitaires de Marseille @univamu Marseille Immunopole Ira Mellman Genentech #RubénPío Cima Universidad de Navarra… packed room!

Beautiful talk by Miriam Merad, MD, PhD! AACR describing phenotypic and functional diversity across DC subsets within the TME

Brilliant talk by Eric Vivier Innate Pharma describing Innate's portfolio of biologics aimed at modulating of NK cell and CD8 T cell functions in TME. Very exciting to see unpublished data on bi-specific engagers as well as on adenosine pathway.